The tumour-suppressor protein p53 is often mutated in cancer. But it seems that p53 deficiency is not all bad, and inhibiting this protein might mitigate toxic side effects of chemotherapy and radiotherapy.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Changes in allelic imbalances in locally advanced breast cancers after chemotherapy
British Journal of Cancer Open Access 18 September 2007
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Christophorou, M. A., Ringhausen, I., Finch, A. J., Brown Swigart, L. & Evan, G. I. Nature 443, 214–217 (2006).
Efeyan, A., Garcia-Cao, I., Herranz, D., Vaelasco-Miguel, S. & Serrano, M. Nature 443, 159 (2006).
Christophorou, M. A. et al. Nature Genet. 37, 718–726 (2005).
Sherr, C. J. et al. Cold Spring Harb. Symp. Quant. Biol. 70, 129–137 (2005).
Bensaad, K. & Vousden, K. H. Nature Med. 11, 1278–1279 (2005).
Tolbert, D., Lu, X., Yin, C., Tantama, M. & Van Dyke, T. Mol. Cell. Biol. 22, 370–377 (2002).
Eymin, B. et al. Mol. Cell. Biol. 26, 4339–4350 (2006).
Bertheau, P. et al. Lancet 360, 852–854 (2002).
Westphal, C. H. et al. Cancer Res. 58, 5637–5639 (1998).
Schmitt, C. A. et al. Cancer Cell 1, 289–298 (2002).
Strom, E. et al. Nature Chem. Biol. 2, 474–479 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berns, A. Can less be more for p53?. Nature 443, 153–154 (2006). https://doi.org/10.1038/443153a
Published:
Issue Date:
DOI: https://doi.org/10.1038/443153a
This article is cited by
-
Changes in allelic imbalances in locally advanced breast cancers after chemotherapy
British Journal of Cancer (2007)